CIDRAP newsletters options
As the virus evolves and spread patterns change, existing control tools might not be enough.
Long-term brain-related complications may be more tied to overall illness severity and hospitalization than specific cause, the authors said.
The strain of Shigella sonnei is non-susceptible to several classes of antibiotics, and health officials say it's likely to spread.
Nirsevimab was 83.2% effective in preventing hospitalization for RSV-associated lower respiratory tract infections.
A study found that 24% of sampled sinks in an Israeli hospital were contaminated with carbapenemase-producing Enterobacteriaceae, with the same strain found in patients.
Children given 5 days of amoxicillin-clavulanate had a lower recurrence of urinary tract infections than those who received the standard 10-day course.
More than 200 US hospitals are run by such firms.
More than 1 million deaths in Africa in 2019 were associated with antimicrobial resistance, and 25% of those deaths were directly attributable to a drug-resistant pathogen.
Emergency department visits for COVID were highest in infants and older adults.
The researchers say healthcare providers, public health officials must encourage vaccination, especially for those at highest risk.
Researchers looked at blood levels of serum inflammatory proteins (cytokines), antibodies, and brain (neuroglial) injury proteins.
Over the course of the study, most participants were eligible for antiviral use.
Cases also continue from China and Singapore in the Western Pacific region.
The H5N6 case, as well as 2 new H9N2 cases, were in Sichuan province.
While antiviral drugs are widely available, the researchers say they are underused, perhaps because patients fear viral rebound after treatment.
Investigators say the results of the randomized trial likely reflect low adherence among participants assigned to receive doxycycline postexposure prophylaxis.
In Antarctica, 48 bird species and 26 marine mammal species inhabit the region, some of which live in dense colonies.
If approved, V116 would be the first pneumococcal conjugate vaccine specifically designed for adults.
The step clears the way for a broader rollout of R21/Matrix-M, which the WHO recommended in October.
During the next 5 years, the farm won't be able to hold cervids—members of the deer family—and must maintain fences and allow routine inspections.